Text Size

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Rajavithi Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Rajavithi Hospital
ClinicalTrials.gov Identifier:
NCT01546376
First received: March 2, 2012
Last updated: March 6, 2012
Last verified: January 2009
History of Changes
  Purpose

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .


Condition Intervention
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
 Radiation: Radiation therapy
Other: Venepuncture

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Resource links provided by NLM:

MedlinePlus related topics: Cancer HIV/AIDS
U.S. FDA Resources

Further study details as provided by Rajavithi Hospital:

Estimated Enrollment: 100
Study Start Date: August 2009
Groups/Cohorts Assigned Interventions
HIV-cancer patients who recived RT Radiation: Radiation therapy
External photon beam radiation therapy dosage 4000-7000 CGy
Other: Venepuncture
Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

HIV positive cancer patients Curative RT treatment

Criteria

Inclusion Criteria:

  • Age 18-65 years
  • HIV positive cancer patients
  • Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks

Exclusion Criteria:

  • CD4 count < 200 cell/ml and not received anti retro viral
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01546376

Contacts
Contact: Pathomphorn Siraprapasiri, MD 66-89-6662960 spathomphorm@gmail.com

Locations
Thailand
Rajavithi Hospital Recruiting
Bangkok, Thailand, 10400
Contact: Pathomphorn Siraprapasiri, MD     66-89-6662960     spathomphorn@gmail.com    
Sponsors and Collaborators
Rajavithi Hospital
  More Information

No publications provided

Responsible Party: Rajavithi Hospital
ClinicalTrials.gov Identifier: NCT01546376     History of Changes
Other Study ID Numbers: THAIHIV001
Study First Received: March 2, 2012
Last Updated: March 6, 2012
Health Authority: Thailand: Thai Society of radiation oncology
Thailand: Rajavithi Hospital

ClinicalTrials.gov processed this record on May 22, 2013